HomeProductsBioactive CompoundsGPCR & G Protein TargetsAdenosine ReceptorPreladenant
Chemical structure of CAS 377727-87-2

Preladenant

CAS No.377727-87-2
MDL No.MFCD17167056
MFC25H29N9O3
MW503.60
InChI KeyDTYWJKSSUANMHD-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.377727-87-2
Product NamePreladenant

Biological Targets

ADORA2A

Associated Conditions

neoplasm·Parkinson disease·liver disease
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Discovery of phosphoric acid mono-{2-[(E/Z)-4-(3,3-dimethyl-butyrylamino)-3,5-difluoro-benzoylimino]-thiazol-3-ylmethyl} ester (Lu AA47070): a phosphonooxymethylene prodrug of a potent and selective hA(2A) receptor antagonist.

Journal of medicinal chemistry • Vol. 54, Issue 3 • 2011
PMID: 21210664DOI: 10.1021/jm1008659

Recent developments in adenosine receptor ligands and their potential as novel drugs.

Biochimica et biophysica acta • Vol. 1808, Issue 5 • 2011
PMID: 21185259PMC: PMC3437328DOI: 10.1016/j.bbamem.2010.12.017

Preladenant, a selective A(2A) receptor antagonist, is active in primate models of movement disorders.

Experimental neurology • Vol. 225, Issue 2 • 2010
PMID: 20655910DOI: 10.1016/j.expneurol.2010.07.011

Characterization of major degradation products of an adenosine A2A receptor antagonist under stressed conditions by LC-MS and FT tandem MS analysis.

Journal of mass spectrometry : JMS • Vol. 45, Issue 2 • 2010
PMID: 19911413DOI: 10.1002/jms.1695

Documentation

Similar Products